aluminum hydroxide, magnesium hydroxide, drug combination and warfarin

aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with warfarin in 1 studies

Compound Research Comparison

Studies (aluminum hydroxide, magnesium hydroxide, drug combination)	Trials (aluminum hydroxide, magnesium hydroxide, drug combination)	Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination)	Studies (warfarin)	Trials (warfarin)	Recent Studies (post-2010) (warfarin)
253	100	17	36,573	2,143	14,728

Protein Interaction Comparison

Protein	Taxonomy	aluminum hydroxide, magnesium hydroxide, drug combination (IC50)	warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1	Homo sapiens (human)		0.0088

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kirch, W; Laeis, P; Püchler, K	1

Other Studies

1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and warfarin

Article	Year
The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:1 Topics: Administration, Oral; Adult; Aluminum Hydroxide; Biological Availability; Blood; Digoxin; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Hydrolysis; Imidazoles; Injections, Intravenous; Magnesium Hydroxide; Male; Olmesartan Medoxomil; Tetrazoles; Warfarin	2001

Article

Year

The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2001, Volume: 19, Issue:1

Topics: Administration, Oral; Adult; Aluminum Hydroxide; Biological Availability; Blood; Digoxin; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Hydrolysis; Imidazoles; Injections, Intravenous; Magnesium Hydroxide; Male; Olmesartan Medoxomil; Tetrazoles; Warfarin

2001